摘要 |
The compounds and their pharmaceutically acceptable salts are useful as tachyquinine inhibitors which act in NK1, NK2 and NK3 receptors or a combination of two or more of them. They have the formula where A is CO, SO2 or CH2; Ar1 is phenyl, optionally substituted by one or more substituents selected from halogen, C1-6 alkoxy, optionally substituted by one of more halogen, and C1-6 alkyl, optionally substituted with one or more halogen, X1 is C3-7 cycloalkyl, aryl or C1-6 alkyl, the above C1-6 alkyl is, optionally, substituted with fluoro, CO2H, CO2(C1-4 alkyl), C3-7 cycloalkyl, adamamntyl, aryl or het, and the above C3-7 cycloalkyl is, optionally, substituted with one or two substituents each individually selected from C1-4 alkyl, C3-7 cycloalkyl, C1-4 alkoxy, OH, F, fluoro(C1-4 alkyl) and fluoro(C1-4 alkoxy); X is direct bond or NR1; R is SO2 aryl, SO2(C1-6 alkyl), optionally substituted by one or more halogen), (a) or (b). 38 claims
|